Post Reply
4921-4940 of 5075
shorted at 0.33. waiting to buy back at 0.27
good luck to those shorting
290 - 310 good spot until next gd announcement
cannot short long term this one long term got good potential until first earnings they target 800m sales 1st 5 year
You got guts leh shorting this sort of pharma stock, i don' t dare because shit turns either way too quickly.
machidrain ( Date: 28-Apr-2020 09:16) Posted:
|
shrot ah gogogo
dont sleep on this!!
Thanks to shortists $0.35 shortly :)
huat. another biolidics. run if u feel things are getting bad. watching.
Exciting day ahead. Looks like lots of fake sell again
long day of gains ahead!!
crash
ystd selling stronger than buying
Daxtheman ( Date: 28-Apr-2020 08:53) Posted:
|
@machidrain, i m neutral on this counter " if it looks like shorting day & HUAT" , what if later it becomes LONGing day, will it be FUK? Lolllllllll
machidrain ( Date: 28-Apr-2020 08:37) Posted:
|
Matching up. Should be good higher opening and run up considering that the buying is strong at last closing
Pre-market does not means on-market! Wait for REALTIME to officilly start first then start SHOOTING your comments or lese when REALTIME starts & whatever u comment Pre-market becomes opposite, EXTREMELY VERY MALU leh! Lolllllllllll
Just few days ago, it was trading at 15c. Good luck to those who wants to jump in now. FOMO will kill u.
looks like shorting day. huat
This is not just a one product company.
From Investor-One :
Here are some information that may have attracted investors to iX Biopharma:
- iX Biopharma&rsquo s patented WaferiX dissolvable wafer drug delivery technology has been applied to their products, and give it a competitive edge.
- Wafesil (Generic Viagra) is the first sub-lingual sildenafil product to receive regulatory approval globally.
- WaferMine, a sublingual Ketamin product for pain management, claimed to be non-addictive (unlike opioids), is in advanced stage of clinical trials.
- To date, the Group has successfully registered 21 products with the Therapeutic Goods Australia with several products in the pipeline.
- Revenues from its nutraceuticals division which sells products in WaferiX format have just started coming in. This includes LumeniX for skin lightening and anti-aging and WafeRest for the promotion of sleep.
- iX Biopharma&rsquo s operating model has shifted from being focused solely on research and development, to encompass manufacturing, sales and marketing.
Good strength in American markets. Good chance for the rally of IX Biopharma today considering it has broken 3 year highs.
Further run expected. Think that it should cross 0.40 today.
Good luck and let see.
Further run expected. Think that it should cross 0.40 today.
Good luck and let see.